ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years
Pavel Stupakov
Matched on ORCID iD 0009-0003-5828-1765; OpenAlex author ID A5057036089. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 4
- Pancreatic cancer fibrosis activates protumorigenic Schwann cells through a nuclear mechanosensing mechanism. Co-author DOI 10.1136/gutjnl-2025-337316↗
- Invasion status stratifies the composition of the human pancreatic cancer perineural niche Co-author DOI 10.64898/2026.08.05.743048↗
- Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer. Co-author DOI 10.3390/cancers13020249↗
- Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1159/000493466↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Richard J. Wong · 2 shared papers, 2026 · strength 0.53
- Sylvie Deborde · 2 shared papers, 2026 · strength 0.53
- İhsan Ekin Demir · 2 shared papers, 2021–2026 · strength 0.39
- Olca Baştürk · 1 shared paper, 2026 · strength 0.26
- Zainab Hussain · 1 shared paper, 2026 · strength 0.26
- Nuray Tezcan · 1 shared paper, 2026 · strength 0.26
- Mara H. Sherman · 1 shared paper, 2026 · strength 0.26
- Joan Massagué Solé · 1 shared paper, 2026 · strength 0.26
- Helmut Frieß · 2 shared papers, 2019–2021 · strength 0.23
- Lei Ren · 1 shared paper, 2021 · strength 0.12
- Rüdiger Göß · 1 shared paper, 2021 · strength 0.12
- Ayse Ceren Mutgan · 1 shared paper, 2021 · strength 0.12
- Okan Safak · 1 shared paper, 2021 · strength 0.12
- Guralp Onur Ceyhan · 1 shared paper, 2021 · strength 0.12
- Jan Goesta D’Haese · 1 shared paper, 2019 · strength 0.11
- Benedikt K. Kaufmann · 1 shared paper, 2019 · strength 0.11
- Beat Gloor · 1 shared paper, 2019 · strength 0.11
- Dejan V. Radenkovic · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.